General Information
Status
Completed: Recruitment, data collection, and data quality management completed
Description
Identification of epigenetic and cerebral proxy markers linking early life adversities and adult anxiety disorders
ELAnx
ID:
65
DZPG Site:
Tübingen
Contact
PI
Prof. Dr. Vanessa Nieratschker
Further PIs
Dr. Benjamin Kreifelts Prof. Dr. Andreas Fallgatter
Survey Results
Is it an interventional or non-interventional study?
- Non-interventional
Specification of study type
- Case-control
Is it a mono- or multicentric study?
Monocentric
Is it a single or multi country study?
Single
Who are participants?
- General population
- Patients with specific diseases
Which diseases? (ICD-11 classification)
- Mental, behavioural or neurodevelopmental disorders (06)
Mental, behavioural or neurodevelopmental disorders (ICD-11 classification)
- Anxiety or fear-related disorders
Recruitment setting
- General population
- Hospital
- Outpatient
Obtained sample size
160
Start of recruitment
2017
End of recruitment
2021
Minimum age of participants
18
Maximum age of participants
65
Data sources for the study
- Biological samples
- Imaging data
- Interview
- Questionnaire
- Omics technology
Is it planned to share the data?
Yes, there is a plan to make data available
Are further follow-ups planned?
Yes
Is there consent to re-contact participants?
Yes
Is the implementation of further study components possible?
No
Biobank Module
Which material did you collect?
- Blood
What type of blood collection tubes did you use?
- EDTA
- PAXgene/Tempus
Which type of data did you collect from EDTA?
- clin-chem
- Genetic
- Epigenetic
Which data did you collect from PAXgene/Tempus?
- Gene expression